Dermatological life quality index in psoriasis out patients: the changing trend

K. Parimalam; S. Sanjeetha Fathima

doi:10.18203/issn.2455-4529.IntJResDermatol20190239

Authors

K. Parimalam Department of Dermatology, Government Stanley Medical College and Hospital, Chennai, Tamil Nadu
S. Sanjeetha Fathima Department of Dermatology, Government Stanley Medical College and Hospital, Chennai, Tamil Nadu

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20190239

Keywords:

Psoriasis, DLQI, Quality of life

Abstract

Background: Psoriasis is a chronic inflammatory disease characterized by remissions and exacerbations, having great impact on social and psychological aspects. From mild plaque psoriasis to more severe pustular and erythrodermic forms with or without joint involvement, is known to have a negative impact on QOL (Quality of Life). Appropriate treatment will improve both disease outcome and QOL in patients. The objective of the study was to assess QOL in psoriasis patient of different age group, type, duration and severity of disease, and their response to this assessment.

Methods: A cross sectional study was done with pretested DLQI questionnaire on 101 psoriasis patients, in a government hospital. Interpretation of score and impact on QOL was done and graded as mild, moderate, considerable, severe and very severe.

Results: In our study, females outnumbered males with male female ratio of 1:1.5. The mean age 39.56±16.029 years. No significant association was noted between grade of affection and demographic variants. Most of them had moderate impact on QOL. QOL was worst affected in patients <5 years of disease duration. 85% of the patients felt happy & 15% felt neutral on being evaluated by this questionnaire.

Conclusions: It is suggested that DLQI is assessed in all new/patients with less than 5 years of disease. Appropriate systemic/photo therapy to be initiated even in mild disease if there is negative impact on the QOL. Assessment of QOL strengthens the doctor-patient rapport and improves better patient adherence to therapy and achieves faster and better control of the disease.

Metrics

Metrics Loading ...

Author Biographies

K. Parimalam, Department of Dermatology, Government Stanley Medical College and Hospital, Chennai, Tamil Nadu

Professor & HOD, Department of Dermatology,
Govt Stanley Medical College, Chennai-1.

S. Sanjeetha Fathima, Department of Dermatology, Government Stanley Medical College and Hospital, Chennai, Tamil Nadu

Resident, Department of Dermatology,
Govt Stanley Medical College, Chennai-1.

References

Ghosh SK, Roy AK. Puvasol therapy in Psoriasis, Indian J Dermatol. 1997;42(3):168-9.

Vardy D, Besser A, Amir M, Gesthalter B, Biton A, Buskila D. Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol. 2002;147:736-42.

National Psoriasis Foundation Benchmark Survey Available at: http://www.psoriasis.org/files/pdfs/ press/npfsurvey.pdf. Accessed on 3 April 2006.

Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis:A population-based cohort study. Arch Dermatol. 2010;146:891–5.

de Arruda LH, De Moraes AP. The impact of psoriasis on quality of life. Br J Dermatol. 2001;144:33–6.

Heydendael VM, de Borgie CA, Spuls PI, Bossuyt PM, Bos JD, de Rie MA. The burden of psoriasis is not determined by disease severity only. J Investig Dermatol Symp Proc. 2004;9(2):131–5.

Rapp SR, Cottrell CA, Leary MR. Social coping strategies associated with quality of life decrements among psoriasis patients. Br J Dermatol. 2001;145:610-6.

Darjani A, Heidarzadeh A, Golchai J, Sadr-Eshkevari S, Alizadeh N, Arami M, and Nichhah N. Quality of Life in Psoriatic Patients:A Study Using the Short Form-36. Int J Prev Med. 2014;5(9):1146–52.

Feldman SR, Fleischer AB Jr, Reboussin DM, Rapp SR, Bradham DD, Exum ML, et al. The economic impact of psoriasis increases with psoriasis severity. J Am Acad Dermatol. 1997;37:564-9.

Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol. 1995;132:236-44.

Mazzotti E, Barbaranelli C, Picardi A, Abeni D, Pasquini P. Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis. Acta Derm Venereol. 2005, 85:409-13.

Soltandehghan K, Najafi-Ghezeljeh T. Relationship Between Quality of Life and Disease Severity in Patients with Psoriasis. NPT. 2017;4(3):143-5.

Sampogna F, Chren MM, Melchi CF, Pasquini P, Tabolli S, Abeni D. Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. Br J Dermatol. 2006;154(2):325-31.

Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R. Quality of life in patients with psoriasis. Health Quality Life Outcomes 2006;4:35.

Barot PA, Brahmbhatt NY, Ninama HV, Kharadi DB, Malhotra SD. Quality of life in patients with psoriasis at a Tertiary care teaching hospital –a cross Sectional study. NJMR. 2015;5(2):95-7.